Skip to content

Clinical trials

Completed Hemoglobinuria, Paroxysmal trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemoglobinuria, Paroxysmal Status: Completed Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20023
20031
20044
20054
20062
20072
20083
20095
20101
20111
20122
20155
20164
20177
20188
20199
20204
20218
20225
202310
20244
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed100

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.23
Novartis Pharmaceuticals6
Apellis Pharmaceuticals, Inc.5
St. Jude Children's Research Hospital5
Chengdu Suncadia Medicine Co., Ltd.4
Wuhan Createrna Science and Technology Co., Ltd4
AKARI Therapeutics3
AO GENERIUM3
Haisco Pharmaceutical Group Co., Ltd.3
National Heart, Lung, and Blood Institute (NHLBI)3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemoglobinuria, Paroxysmal100
Anemia, Aplastic12
Leukemia, Myeloid, Acute11
Lymphoma, Non-Hodgkin11
Myelodysplastic Syndromes11
Hemoglobinuria9
Hemolysis9
Hodgkin Disease9
Precursor Cell Lymphoblastic Leukemia-Lymphoma9
Leukemia7

Trials

Showing 51 to 75 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.